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Macrophage aging is pathogenic in numerous diseases, including age-related macular degeneration (AMD), a
leading cause of blindness in older adults. Although prior studies have explored the functional consequences of
macrophage aging, less is known about its cellular basis or what deﬁnes the transition from physiologic aging
to disease. Here, we show that despite their frequent self-renewal, macrophages from oldmice exhibited numer-
ous signs of aging, such as impaired oxidative respiration. Transcriptomic proﬁling of agedmurine macrophages
revealed dysregulation of diverse cellular pathways, especially in cholesterol homeostasis, that manifested in al-
tered oxysterol signatures. Although the levels of numerous oxysterols in human peripheral bloodmononuclear
cells and plasma exhibited age-associated changes, plasma 24-hydroxycholesterol levels were speciﬁcally asso-
ciated with AMD. These novel ﬁndings demonstrate that oxysterol levels can discriminate disease from physio-
logic aging. Furthermore, modulation of cholesterol homeostasis may be a novel strategy for treating age-
associated diseases in which macrophage aging is pathogenic.








Age-relatedmacular degeneration (AMD) is a leading cause of blind-
ness in adults over 50 years of age in industrialized nations [1]. Early
AMD is characterized by the presence of lipoproteinaceous deposits or
drusen under the retinal pigment epithelium (RPE) and/or thickening
of Bruch's membrane. Although early AMD is not always associated
with vision loss, it is a major risk factor for progression to one of two
forms of advanced AMD: a dry form, characterized by death of RPE
cells called geographic atrophy (GA) that eventually leads to death of
overlying photoreceptors, or wet (neovascular) form, characterized by
abnormal vascular proliferation underneath the retina called choroidal
neovascularization (CNV). While both advanced dry and wet AMD can
cause vision loss, wet AMD accounts for a signiﬁcant fraction of the
vision loss associated with AMD [2] and can often be acute and
catastrophic.
The currentmainstay therapies for wet AMD focus on combating ab-
normal angiogenesis by blocking vascular endothelial growth factor
(VEGF) with targeted anti-VEGF agents. These treatments stabilize dis-
ease in amajority of patients and signiﬁcantly improve visual outcomes
in 30–40% of wet AMD patients [3–5]. However, these therapies often
require frequent visits for repeated intraocular injections, which places
a signiﬁcant burden on patients and caregivers [6]. Moreover, repeated
intravitreal injections are also associatedwith risks of their own, such as
infection, scleral thinning, and long-term visual acuity loss due to con-
tinued atrophy of the RPE and photoreceptors [3, 7]. Perhaps more im-
portantly, anti-VEGF agents do not address the pathophysiology that
causeswet AMD [8]. Therefore, there is need for further research to clar-
ify the molecular and cellular mechanisms involved in the transition
from physiologic aging to AMD and to understand the pathogenesis un-
derlying the progression from early to wet AMD, which may lead to
novel strategies for targeted intervention.
In the past fewdecades, we and others have demonstrated thatmac-
rophages, key cells of the innate immune system, play important roles
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in the pathogenesis of wet AMD [9–12]. Moreover, it has become in-
creasingly clear that the ability of macrophages to polarize to different
activation states is an important factor affecting whether macrophages
promote health or disease [13]. Depending on dynamic tissue signals
and the surrounding micro-environment, macrophages can polarize to
a classical pro-inﬂammatory (M1-like) phenotype, an alternative anti-
inﬂammatory (M2-like) phenotype, or some intermediate between
these two extremes [14]. To further complicate matters, the identity of
the speciﬁc activators that cause macrophage polarization may also af-
fect the macrophage phenotype [15].
Previously, we reported that aged macrophages tend to skew to the
anti-inﬂammatoryM2-like phenotype and are less able to inhibit abnor-
mal angiogenesis [16]. Furthermore, aged macrophages exhibit both
impairments in cholesterol efﬂux [17] and abnormalities in IL-10 and
downstreamSTAT3 signaling pathways that contribute to this age-asso-
ciated drift towardsM2-like polarization [18]. These age-associated im-
pairments in cholesterol efﬂux and other lipid-related pathways may
have mechanistic consequences in disease pathogenesis [19]. This pos-
sibility is supported by the fact that polymorphisms in lipid-related
genes, such as hepatic lipase (LIPC), ATP-binding cassette transporter
member 1 (ABCA1), and cholesterol ester transfer protein (CETP), are
associatedwith advancedAMD [20].Moreover, drusen, a clinical feature
of early AMD, are lipid-rich, further supporting our hypothesis that
dysregulated lipid homeostasis contributes to AMD. Despite these ad-
vances, the global programmatic changes that occur duringmacrophage
aging need further elucidation. It is also unclear what subset of these
changes are associated with physiologic aging or are pathologic and
contribute to age-associated disease.
In this study, we sought to delineate the cellular pathways involved
in macrophage aging and identify potential markers that may distin-
guish age-associated changes that are physiologic versus those that
promote age-associated disease. Our results suggest that impaired
cholesterol homeostasis in macrophages is a central process
perturbed during aging and that these changes lead to alterations
in oxysterol signatures that can distinguish AMD from physiologic
aging. These ﬁndings may allow physicians to monitor progression
of disease with quantiﬁable serum markers and may potentially
lead to novel therapeutic strategies not only for AMD but also for
other age-associated diseases in which alternatively-activated mac-
rophages are pathogenic.
2. Materials and Methods
2.1. Animals
All animal experiments were approved by the Institutional
Animal Care and Use Committee (IACUC) and performed in accor-
dance with the Washington University School of Medicine Animal
Care and Use guidelines. We obtained old (i.e., ~18-month-old), fe-
male wild-type C57BL/6J mice from the National Institute on Aging
(Bethesda, MD) and compared them to strain-matched young (i.e.,
~3-month-old), female wild-type C57BL/6J controls. We harvested
peritoneal macrophages ﬁve days after elicitation with a 2-ml intra-
peritoneal injection of 4% thioglycollate broth (Sigma-Aldrich, St.
Louis, MO). We harvested splenic macrophages by performing posi-
tive magnetic cell separation with the PE selection kit (Stem Cell
Technologies) and PE anti-F4/80 monoclonal antibody (clone:
BM8; eBioscience, Waltham, MA), following manufacturer's instruc-
tions. We cultured peritoneal and splenic macrophages in Gibco™
RPMI 1640 medium (Thermo Fisher Scientiﬁc, Waltham, MA) sup-
plemented with 10% fetal bovine serum (FBS; Atlanta Biologicals,
Flowery Branch, GA) and 1% penicillin-streptomycin (Thermo Fisher
Scientiﬁc). When indicated, we treated macrophages with 25 or 50
μg/ml of oxidized LDL (oxLDL; Alfa Aesar, Haverhill, MA) for 24 h
prior to further analysis.
2.2. OCR Measurements
To perform metabolic characterization, we measured the oxygen
consumption rate (OCR) of peritoneal macrophages as a surrogate
marker for oxidative respiration with the XF96 Extracellular Flux Ana-
lyzer (Seahorse Bioscience, North Billerica, MA). In short, we plated
peritoneal macrophages in Seahorse XF96 cell culture microplates
(Seahorse Bioscience) at 100,000 cells per well. On the morning of the
experiment, we washed the cells and replaced the medium with
Seahorse assay medium (Seahorse Bioscience) supplemented with
25 mM glucose (Sigma-Aldrich, St. Louis, MO) and 1 mM sodium pyru-
vate (Thermo Fisher Scientiﬁc) and adjusted the pH to 7.4. After incuba-
tion in a non-CO2 incubator at 37 °C for 1 h, we measured OCR at
baseline and after sequential treatment with the following chemicals
from the Mito Stress Test kit (Seahorse Bioscience): 3 μM oligomycin,
5 μM carbonyl cyanide 4-(triﬂuoromethoxy) phenylhydrazone (FCCP),
and 1 μM rotenone/antimycin A (rot/AA). Each cycle consisted of
2 min of mixing and a 1-min pause, followed by a 5-min measurement
period; we repeated each cycle 3–4 times. We normalized the back-
ground of all measurements by subtracting the average OCR of each
sample after treatment with rot/AA.
2.3. Gene Expression Analysis
We extracted total RNA from peritoneal macrophages with the
RNeasyMini kit (Qiagen) and prepared cDNAwith the High-Capacity
Reverse Transcription kit (Applied Biosystems), following manufac-
turer's instructions. We performed quantitative PCR ampliﬁcation
of cDNA using either the TaqMan® probe-based gene expression
assay for p16INK4a (Mm00494449_m1; Applied Biosystems) or cus-
tom TaqMan® Array Plates (Applied Biosystems) for lipid-related
genes with the assays indicated in Supplemental Table S1. In all
cases, we used the ΔΔCT method, normalizing to Actb, 18sRNA,
Gapdh, or the geometric mean of a combination of these endogenous
controls.
2.4. Transcriptomic Proﬁling
We isolated total RNA from peritoneal macrophages with the
mirVana kit (Ambion), performed cDNA ampliﬁcation with the Ova-
tion® Pico kit (NuGEN, San Carlos, CA), and performed target labeling
with the Encore® Biotin kit (NuGEN), according to manufacturer's in-
structions. We then performed whole transcriptome proﬁling of
young and aged peritoneal macrophages using Mouse Gene (MoGene)
1.0 ST arrays processed with Affymetrix Expression Console
(v1.3.1.187) at standard settings (RMA background correction, median
polish summarization, and quantile normalization) to generate inten-
sity values.We assigned each probeset of theMoGene 1.0 array a detec-
tion call of ‘mean+2× SD’ of the negative controls.We performed data
quality control to identify potential outliers by principal component
analysis (PCA) plot and hierarchical clustering, aswell as by quality con-
trol (QC)metrics (all probeset RLEmeans N 0.25) in Expression Console.
From this QC, we omitted one sample in the young group. We then ﬁl-
tered data by probeset type (“main” in MoGene 1.0) and by detection
call (any probeset without a “detected” call in any of the samples was
removed). Any probeset without a gene symbol in the MoGene 1.0
data was also removed. 18,066 MoGene 1.0 probesets (from the total
of 35,556) were kept for further analysis. We analyzed the data using
the R package “limma” and generated gene lists based on P-values and
false detection rate (FDR) q-values. We performed gene ontology
(GO), pathway map, and interactome analyses with MetaCore™
(Clarivate Analytics, Philadelphia, PA). Themicroarray data are available
at theGeneExpressionOmnibus (GEO) at NCBI under accessionnumber
GSE111382.
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2.5. Flow Cytometry
We plated peritoneal macrophages on untreated Petri dishes and
allowed them to adhere overnight. The next morning, we lifted cells
by incubating for 5 min in ice-cold Dulbecco's phosphate-buffered sa-
line (DPBS; Thermo Fisher Scientiﬁc) without calcium or magnesium
and scraping gently.We next ﬁltered cells through a 40 μm cell strainer,
washed themwith DPBS, and resuspended them in DPBS containing 5%
FBS, 10 mM HEPES, 1 mM EDTA, and TruStain fcX™ antibody
(BioLegend, San Diego, CA). We stained 105 to 106 cells with APC anti-
mouse CD36 (clone: HM36; BioLegend), PE/Cy7 anti-mouse CD64
(clone: ×54–5/7.1; BioLegend), and PE anti-mouse F4/80 (clone: BM8;
eBioscience) antibodies for 20 min on ice. We then washed and resus-
pended cells in DPBS and acquired data on a BD X-20 or BD LSR II ﬂow
cytometer (BD Biosciences, San Jose, CA). We analyzed and visualized
data with FlowJo v10.
2.6. Human Subjects
This studywas approvedby theHumanResearch ProtectionOfﬁce of
Washington University School of Medicine and adhered to the Declara-
tion of Helsinki.We obtained informed consent fromall subjects prior to
blood collection. To purify peripheral blood mononuclear cells (PBMCs)
and plasma, we performed density gradient centrifugation with BD
Vacutainer CPT™ Cell Preparation Tubes (Franklin Lakes, NJ), following
manufacturer's instructions. We classiﬁed patients as no AMD, early
AMD, or wet AMD based on established clinical criteria [21]. Early
AMD patients had either moderate drusen (N63 μm) or pigment
changes in at least one eye but no CNV or GA in either eye at the time
of sample collection. Wet AMD patients had CNV in at least one eye at
the time of sample collection.We stored all samples at−80 °C until fur-
ther analysis. To determine the appropriate sample size, we performed
an a priori power analysis with G*Power 3.1 [22]. Estimating an effect
size d of 0.6 based on pilot experiments, we calculated that we needed
94 subjects with an allocation ratio of 1.5:1 to detect a signiﬁcant
difference between the groups at the two-sided α= 0.05 level with
80% power. For the subanalysis, we performed chart review to identify
the closest total plasma cholesterol measurement obtained within
3.5 years of the date of sample collection.
2.7. Oxysterol Proﬁling by LC–MS/MS
We extracted and quantiﬁed oxysterol levels from murine perito-
neal macrophage pellets, the supernatant of murine peritoneal
macrophages, human PBMC pellets, and human plasma samples as pre-
viously described [23]. Brieﬂy, we added deuterated oxysterols to the
samples as internal standards and then extracted oxysterols withmeth-
anol. We derivatized the extracted oxysterols and their internal stan-
dards with N,N-dimethylglycinate (DMG) to increase MS sensitivity.
We performed oxysterol analysis with a Shimadzu 20 CE HPLC system
(Kyoto, Japan) and a LeapPAL autosampler coupled to a tandem mass
spectrometer (API 4000; Applied Biosystems) operated in MRMmode.
We used positive ion ESI mode for detection of the derivatized
oxysterols, injecting study samples in duplicate for data averaging. We
conducted data processing with Analyst 1.5.1 (Applied Biosystems)
and determined relative levels of each oxysterol by comparing its mea-
surement with that of its corresponding deuterated internal standard.
We normalized themurinemacrophage oxysterol levels to cell number,
murine supernatant levels to volume, human PBMC oxysterol levels to
protein content, and human plasma oxysterol levels to volume. To nor-
malize human samples processed on different days, we used one of the
patient samples as an internal control.
2.8. Statistics
We performed statistical analysis as indicated in the Figure legends
with Prism 5 (GraphPad Software) or SPSS Statistics Version 23 (IBM,
Armonk, NY). We assessed the normality of our data graphically and
with the Kolmogorov-Smirnov test and used appropriate non-paramet-
ric alternatives when necessary.We considered P b .05 to be statistically
Fig. 1. Peritoneal macrophages from old mice exhibit quantiﬁable signs of aging. (a) Aged peritoneal macrophages had reduced oxygen consumption rate (OCR) both at baseline (N=
9/group; 2-tailed, unpaired Welch's t-test) and in response to oligomycin (N = 11–12/group; 2-tailed, unpaired t-test) and signiﬁcantly reduced ATP-linked respiration (b; N =
9/group; 2-tailed, unpaired Welch's t-test). (c) Lipopolysaccharide (LPS)-treated aged peritoneal macrophages also had impaired mitochondrial bioenergetics at baseline (N= 8–12/
group; 2-tailed, unpaired Welch's t-test) and signiﬁcantly reduced ATP-linked respiration (d; N = 6–9/group; 2-tailed, unpaired t-test) compared to LPS-treated young peritoneal
macrophages. (e) Aged peritoneal macrophages had increased mRNA expression of the senescence marker p16INK4a (N = 10/group; 2-tailed, unpaired t-test). Open circles depict
individual data points; horizontal lines depict mean ± SEM (a-e) (* P b .05; ** P b .01; *** P b .001; **** P b .0001).
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signiﬁcant. To model the relationship between PBMC and plasma
oxysterol signatures and AMD, we generated binary logistic regression
models. Our model included the following predictor variables: age at
the time of sample collection, gender, and PBMC/plasma oxysterol
levels. For the subanalysis, we generated an additional binary logistic re-
gressionmodel, which included the following predictor variables: age at
the time of sample collection, gender, plasma 24-HC levels, and total
plasma cholesterol. For all regression models, we assessed ﬁt with the
Hosmer-Lemeshow lack-of-ﬁt test and performed diagnostics by exam-
ining Cook's distances, leverages, and residual deviances. The ﬁnal re-
ported models had seven omitted cases based on sensitivity analysis.
We checked for problemswith collinearity by examining variance inﬂa-
tion factors (VIF).We used anunadjusted alpha of 0.05 for the binary lo-
gistic regression.
3. Results
3.1. Peritoneal Macrophages from Old Mice Exhibit Features of Aging
Under steady-state conditions, tissue-resident macrophages are
maintained through constant replacement or self-renewal. In many tis-
sues, including the peritoneal cavity, there is extensive replacement of
macrophages as quickly as every 3 weeks [24]. Therefore, we sought
to determine whether macrophages isolated from old (i.e., 18-month-
old)wild-typemice exhibited features of cellular agingwhen compared
tomacrophages isolated from young (i.e., 3-month-old) wild-typemice
despite this short replenishment cycle.
Mitochondrial dysfunction is a well-established hallmark of aging,
and in many tissues, there is an age-dependent decrease in mitochon-
drial oxygen consumption [25]. To determine whether peritoneal mac-
rophages from old mice exhibit mitochondrial dysfunction, we
measured the oxygen consumption rate (OCR) of peritoneal macro-
phages isolated from 3-month-old and 18-month-old mice. The base-
line OCR of peritoneal macrophages from old mice was signiﬁcantly
lower than that of peritoneal macrophages from young mice (Fig. 1a),
indicating reduced basal oxidative respiration. Although both young
and aged peritoneal macrophages appropriately exhibited a reduction
in OCR after treatment with the ATP synthase inhibitor oligomycin,
young peritoneal macrophages maintained a somewhat higher residual
OCR (Fig. 1a). In contrast, both young and aged peritonealmacrophages
demonstrated similar maximal oxidative respiration in response to
the uncoupling agent FCCP (Fig. 1a). The difference between the
baseline OCR and the OCR after oligomycin treatment represents
ATP-linked respiration. Aged peritoneal macrophages exhibited sig-
niﬁcantly reduced ATP-linked respiration (Fig. 1b), indicating mito-
chondrial dysfunction.
Fig. 2. Transcriptomic proﬁling of aged peritoneal macrophages. (a) Aged peritonealmacrophages display numerous transcriptomic changes, which suggest perturbations in various gene
ontology (GO) processes (b) and pathway maps (c). (d) Interactome analysis revealed numerous overconnected transcription factors (TFs) whose known gene targets were
overrepresented in the genes we identiﬁed as dysregulated in aged versus young macrophages.
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Moreover, previous studies report that exposing macrophages to
lipopolysaccharide (LPS) considerably alters their bioenergetic
proﬁle [26]. Furthermore, such a metabolic switch is required for
macrophage activation and affects subsequent inﬂammatory status
[26–28]. We observed distinct mitochondrial respiratory proﬁles
when comparing young and aged, LPS-treated peritoneal macro-
phages: aged peritoneal macrophages exhibited a reduced OCR at
baseline, despite maintaining similar responses to oligomycin and
FCCP (Fig. 1c). Again, aged peritoneal macrophages exhibited signif-
icantly reduced ATP-linked respiration (Fig. 1d). Cumulatively, these
data demonstrate that mitochondrial oxidative metabolism is con-
siderably impaired in peritoneal macrophages isolated from old
mice both at baseline and in response to LPS.
Furthermore, we evaluated the expression of the aging marker
p16INK4a, which is a known senescencemarker in bonemarrow-derived
macrophages [29] and has been shown to accumulate in rodent and
human tissues during aging [30–32]. We found that p16INK4amRNA ex-
pression was signiﬁcantly elevated in aged peritoneal macrophages
compared to young peritoneal macrophages (Fig. 1e). Collectively,
these results conﬁrm that despite their constant renewal, peritoneal
macrophages from old mice exhibit multiple quantiﬁable signs of
aging, including mitochondrial dysfunction and increased expression
of the senescence marker, p16INK4a.
3.2. Aged Macrophages Exhibit Impaired Cholesterol Homeostasis
To determine the speciﬁc cellular processes that are perturbed in
aged macrophages, we proﬁled the transcriptomes of young and aged
macrophages with the GeneChip Mouse Gene 1.0 ST Array (Affymetrix,
Santa Clara, CA). We found that 1080 probe sets were signiﬁcantly dif-
ferentially expressed in aged versus young macrophages (Fig. 2a; P b
.05, FDR b 0.20). The twenty protein-coding genes that were up- or
downregulated with the highest fold change in aged versus youngmac-
rophages are presented in Table 1. To determine whether the identities
of the dysregulated genes were associated with defects in particular
pathways or cellular processes, we ﬁltered for genes with a 1.50-fold-
change cutoff (22.1%, N = 239) and then performed gene ontology
(GO) and pathway map analysis with MetaCore™ (Clarivate Analytics,
Philadelphia, PA). Of interest, the ﬁrst, second, and tenthmost signif-
icant GO processes implicated were sterol biosynthesis, cholesterol
biosynthesis, and cholesterol metabolism, respectively (Fig. 2b).
Consistently, cholesterol biosynthesis was the most signiﬁcant path-
way map implicated by the altered transcriptomic proﬁle of aged
macrophages (Fig. 2c). As expected, the transcriptomic proﬁle of
agedmacrophages also suggested disruptions in numerous other im-
mune response pathways (Fig. 2c). Overall, these results clearly indi-
cate that cholesterol homeostasis is signiﬁcantly perturbed during
macrophage aging.
Given that numerous genes were dysregulated in aged peritoneal
macrophages, we sought to identify candidate transcription factors
(TFs) that may regulate the aging process. Therefore, we performed
interactome analysis to identify over-connected TFs, which may reg-
ulate the observed transcriptomic changes in aged macrophages. Of
interest, two of the top ﬁve most signiﬁcantly overconnected TFs
were sterol regulatory element-binding protein 1 and 2 (SREBP1/
SREBP2; Fig. 2d), which are known master regulators of cholesterol
and lipid homeostasis. These two TFs had connectivity ratios of
14.73 and 15.15, respectively, indicating ~15-fold overrepresenta-
tion of their known targets. These ﬁndings support our assertion
that global lipid homeostatic mechanisms are impaired in aged
macrophages.
To determine the speciﬁc aspects of cholesterol homeostasis that
are impaired in aged macrophages, we analyzed the expression pro-
ﬁle of 113 lipid-related genes in young and agedmacrophages with a
custom quantitative PCR array (Applied Biosystems). We were able
to detect expression of 86.7% (N = 98) of the genes we tested and
found that 30 of these 98 cholesterol-related genes (30.6%) had sig-
niﬁcantly different expression in aged versus young macrophages
(Table 2). When we subdivided these lipid-related genes broadly
by their cellular function, we observed that they encompassed di-
verse biological processes, including cholesterol/lipid biosynthesis,
elimination, transport, and uptake, among other processes. These
ﬁndings once again conﬁrmed that aged peritoneal macrophages ex-
hibit global impairments in their ability to maintain cholesterol and
lipid homeostasis.
Table 2
Expression proﬁling of lipid-related genes in aged and young macrophages.
Cellular function Gene symbol Fold changea P-valueb













Leukotriene signaling Lta4h −1.314 0.050
Alox5ap −1.919 0.050















a Aged versus young peritoneal macrophages; negative fold-change reﬂects decreased
expression in aged macrophages relative to young macrophages.
b Signiﬁcant by 2-tailed Mann-Whitney U test.
Table 1
Top ten up- and down-regulated genes in aged versus young peritoneal macrophages.
Probeset ID Gene symbol Fold changea P-value FDR
10463355 Scd2 −3.645 0.0007 0.0667
10506571 Dhcr24 −2.522 0.0001 0.0361
10347748 Acsl3 −2.406 0.0003 0.0497
10560702 Ceacam19 −2.266 b0.0001 0.0307
10403413 Idi1 −2.070 0.0018 0.0952
10544273 Clec5a −1.996 0.0006 0.0634
10482762 Idi1 −1.977 0.0021 0.1006
10420668 Mir15a −1.969 0.0016 0.0924
10424349 Sqle −1.969 b0.0001 0.0115
10527920 Cyp51 −1.967 0.0012 0.0851
10582879 Csprs 3.771 b0.0001 0.0258
10538126 Gimap4 4.368 0.0052 0.1382
10551025 Cd79a 6.435 0.0018 0.0957
10429520 Ly6d 6.483 0.0028 0.1104
10466172 Ms4a1 7.480 0.0025 0.1050
10392142 Cd79b 7.764 0.0004 0.0552
10458278 Mzb1 9.573 0.0002 0.0469
10523359 Cxcl13 11.166 0.0015 0.0918
10531724 Plac8 11.549 0.0006 0.0634
10429564 Ly6a 12.571 b0.0001 0.0306
a Aged versus young peritoneal macrophages; negative fold-change reﬂects decreased
expression in aged macrophages relative to young macrophages.
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3.3. Aged Macrophages have Altered Intracellular Oxysterol Content
Wepreviously reported that agedmacrophages have higher levels of
intracellular cholesterol related to impaired efﬂux [17], likely related to
the global changes in cholesterol homeostatic mechanisms described
above. The oxidation of cholesterol to generate oxidized derivatives of
cholesterol or oxysterols serves a crucial purpose to facilitate elimina-
tion of excess cholesterol. However, oxysterols themselves also play im-
portant signaling roles in regulating cholesterol homeostasis [33] and
inﬂammation [34] and may therefore promote disease. In addition, ab-
errant oxysterol production can be a sign of increased oxidative stress,
which is known to be pathogenic in AMD [35]. Since our transcriptomic
proﬁling demonstrated that impaired cholesterol homeostasis is a hall-
mark feature of agedmacrophages, we sought to explorewhether these
changes were associated with altered oxysterol signatures, which
would not only provide mechanistic insight into why there is impaired
cholesterol homeostasis but also identify a potential approach for de-
tecting defective cholesterol homeostasis.
Fig. 3. Aged peritoneal macrophages have abnormal oxysterol content. (a-c) Aged peritoneal macrophages contained signiﬁcantlymore intracellular 4β-hydroxycholesterol (4β-HC) and
7-ketocholesterol (7-KC) than their young counterparts at baseline and after treatment with 25 or 50 μg/ml oxidized LDL (oxLDL) (N= 5/group; 2-way ANOVA) and signiﬁcantly more
intracellular cholestane-3β,5α,6β-triol (C-triol) after treatmentwith 50 μg/ml oxLDL (N=5/group; 2-way ANOVAwith Bonferroni post-hoc test). (d-f) Although some comparisonswere
statistically signiﬁcant due to low within-group variance, the supernatants of young and aged peritoneal macrophages contained qualitatively similar levels of 4β-HC, 7-KC, and C-triol
both at baseline and after treatment with oxLDL (N= 5/group; 2-way ANOVA with Bonferroni post-hoc test). (g) Representative ﬂow cytometry plot from young and aged peritoneal
macrophages showing gating on macrophage markers CD64 and F4/80. (h-i) Young and aged peritoneal macrophages exhibited similar CD36 surface expression. Isotype staining (iso)
was identical between groups (N= 5/group; 2-tailed, unpaired t-test). Open circles depict individual data points; horizontal lines depict mean ± SEM (a-f, i) (*** P b .001).
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Using liquid chromatography tandem mass spectrometry (LC–MS/
MS), we measured the most abundant oxysterols, including 4β-
hydroxycholesterol (4β-HC), 7-ketocholesterol (7-KC), and
cholestane-3β,5α,6β-triol (C-triol) in young and aged peritoneal mac-
rophages. We found that aged peritoneal macrophages contained
more 4β-HC and 7-KC compared to young peritoneal macrophages,
both at baseline and after treatment with 25 or 50 μg/ml oxidized LDL
(oxLDL) (Fig. 3a-b). Aged peritoneal macrophages also had increased
C-triol content at baseline and after treatment with oxLDL, but the dif-
ference was statistically signiﬁcant only after treatment with 50 μg/ml
oxLDL (Fig. 3c). To account for the possibility that these increases in in-
tracellular oxysterols may have been inﬂuenced by environmental fac-
tors, we also tested a separate cohort of young and aged mice that
were housed at the same animal facility. Consistent with our original
ﬁndings, these aged peritoneal macrophages also had increased levels
of 4β-HC, 7-KC, and C-triol after treatment with 50 μg/ml oxLDL (Fig.
S1a–c). These ﬁndings demonstrate that aged peritoneal macrophages
have increased intracellular oxysterols upon challenge with oxLDL and
that this difference is likely an effect of age rather than environmental
factors.
We alsomeasured the oxysterol content in the supernatant to deter-
mine whether increased intracellular oxysterol content was associated
with increased oxysterol secretion. Although some comparisons were
statistically signiﬁcant due to low within-group variance, the levels of
4β-HC, 7-KC, and C-triol were qualitatively similar in the supernatant
of both young and aged peritoneal macrophages both at baseline and
after treatment with oxLDL (Fig. 3d–f; Fig. S1d–f). Of note, the levels
of 4β-HC and 7-KC detected in equivalent dilutions of oxLDL were sim-
ilar to those detected in the supernatants of both young and aged peri-
toneal macrophages (Fig. 3d–e; Fig. S1d–e), suggesting that any
differences in the secretion of these two oxysterols were likely masked
by the oxysterols present in the oxLDL itself.
Our ﬁnding of increased intracellular oxysterols in the absence of
changes in extracellular levels suggested that there is increased
oxysterol synthesis associatedwith aging rather than changes in uptake.
In support of this hypothesis, we previously reported that young and
aged macrophages have similar capacity to inﬂux Dil-labeled oxLDL
[17]. Furthermore, using ﬂow cytometry, we found that surface expres-
sion of CD36, a receptor for oxLDLuptake,was similar in young and aged
peritoneal macrophages (Fig. 3g–i), supporting the conclusion that
these differences in intracellular oxysterolswere not likely due to differ-
ences in uptake.
To determine whether these aging-associated changes in oxysterol
signatures were speciﬁc to elicited peritoneal macrophages, we also
measured intracellular oxysterol content and secretion in young and
aged splenic macrophages. We found that aged splenic macrophages
had similar patterns of increased intracellular oxysterols (Fig. S2a–c)
with minimal changes in extracellular oxysterols (Fig. S2d–f). These
ﬁndings indicate that impaired cholesterol homeostasis is associated
with detectable alterations in oxysterol signatures in agedmacrophages
of multiple origins.
3.4. PBMC and PlasmaOxysterol Signatures are Alteredwith Age inHumans
We have previously demonstrated that aged murine macrophages
exhibit functional shifts that are associated with their tendency to pro-
mote AMD [9, 17, 18]. However, it remains unclear which subset of the
age-associated changes described above promote disease rather than
being a part of physiologic aging. To discriminate between these physi-
ologic versus pathologic changes, we assessed whether PBMCs and
plasma samples from healthy human subjects also exhibited changes
in oxysterol signatureswith age andwhether these changeswere differ-
ent in AMDpatients.We chose to process thehuman samplesminimally
without cell sorting or cultures to explore how these oxysterol signa-
tures could be used clinically. Demographic information of the human
subjects is shown in Table 3.
In addition to measuring the same oxysterols we measured in mu-
rine peritoneal macrophages (i.e., 4β-HC, 7-KC, and C-triol), we were
also able to quantify levels of two additional enzymatically generated
oxysterols, 24-hydroxycholesterol (24-HC) and 27-hydroxycholesterol
(27-HC), which were below the limit of detection in the murine sam-
ples. Of interest, we observed a statistically signiﬁcant negative correla-
tion between age and PBMC 7-KC levels (Fig. 4a; Spearman R =
−0.2964, P = .0204), PBMC C-triol levels (Fig. 4a; Pearson R =
−0.3068, P = .0171), and PBMC 24-HC levels (Fig. 4b; Pearson R =
−0.3058, P = .0165). There was no association between age and
PBMC 4β-HC levels (Fig. 4a; Spearman R = −0.0356, P = .7853) or
PBMC 27-HC levels (Fig. 4b; Pearson R=−0.0012, P = .9930). Addi-
tionally, we observed a signiﬁcant positive correlation between age
and plasma C-triol levels (Fig. 4c; Pearson R = 0.2818, P = .0278).
Although not statistically signiﬁcant, there was a trend (0.05 b P b .10)
towards a positive correlation between age and plasma 4β-HC levels
(Fig. 4c; Spearman R = 0.2170, P = .0930). There was no statistically
signiﬁcant correlation between age and plasma 7-KC levels (Fig. 4c;
Spearman R = 0.1172, P = .3683), plasma 24-HC levels (Fig. 4d;
Spearman R = 0.0394, P = .7631), or plasma 27-HC levels (Fig. 4d;
Pearson R = 0.1601, P = .2177). Overall, these ﬁndings suggest that
healthy humans also exhibit age-associated alterations in oxysterol sig-
natures, likely reﬂecting changes in cholesterol homeostasis.
3.5. Plasma 24-hydroxycholesterol Distinguishes AMD from Physiologic
Aging
To further characterize the relationship between age-associated
oxysterol signatures and age-related disease, we recruited human pa-
tients with early or advanced neovascular (wet) AMD and measured
their PBMC and plasma oxysterol levels (Fig. 5a–j). While AMD patients
were signiﬁcantly older than non-AMD control subjects, there was no
difference between the groups on the basis of gender (Table 3). On av-
erage, AMD patients had decreased PBMC 7-KC levels compared to
non-AMD controls (Fig. 5b) but no differences in the other PBMC
oxysterol levels (Fig. 5a/c–e). Moreover, AMD patients had elevated
plasma 4β-HC levels (Fig. 5f), elevated plasma C-triol levels (Fig. 5h), el-
evated plasma 24-HC levels (Fig. 5i), and a trend (0.05 b P b .10) to-
wards elevated plasma 27-HC levels (Fig. 5j) compared to non-AMD
controls. There was no difference in plasma 7-KC levels (Fig. 5g).
Given the known association between AMD and age and the signiﬁ-
cant age difference between the two groups, we performedbinary logis-
tic regression to precisely model the relationship between PBMC or
plasma oxysterol levels and AMD after controlling for age and gender.
We selected PBMC 7-KC, plasma 4β-HC, plasma C-triol, and plasma
24-HC levels as candidates for further analysis since these were the
oxysterols that were signiﬁcantly different between AMD patients and
controls. The binary logistic regression model for a PBMC oxysterol
AMD signature included age, gender, and untransformed PBMC 7-KC
(Table 4). The overall model was statistically signiﬁcant (LR Χ2 = 34.0,
df = 3, P b .001) and had good ﬁt (Χ2 = 9.6, df = 8, P = .294). As
Table 3
Demographic and clinical characteristics of human subjects.
Demographic parameter Control AMD P-value






Male 37 23 .3781b
Female 25 22
AMD status, N
No AMD 62 0 N/A




a Signiﬁcant by 2-tailed Mann-Whitney U test.
b Non-signiﬁcant by χ2 test.
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expected, age was signiﬁcantly associated with AMD (P b .001)
with a beta coefﬁcient of 0.098, indicating that each additional
year of age was associated with increased odds of having AMD
(aOR = 1.10; 95% CI = 1.05 to 1.16). However, after controlling
for age and gender, PBMC 7-KC levels were not associated with
AMD (P = .140).
The binary logistic regressionmodel for a plasma oxysterol AMD sig-
nature included forced entry of age, gender, and any combination of the
candidate plasma oxysterol species through automated forward selec-
tion (Table 5). The ﬁnal model was statistically signiﬁcant (LR Χ2 =
44.9, df = 3, P b .001), had good ﬁt (Χ2 = 14.2, df = 8, P= .078), and
included age, gender, and plasma 24-HC levels. As expected, age was
signiﬁcantly associated with AMD (P b .001) with a beta coefﬁcient of
0.107, indicating that each additional year of agewas associatedwith in-
creased odds of having AMD (aOR=1.113; 95% CI: 1.06 to 1.17). Of sig-
niﬁcant interest, even after controlling for age and gender, 24-HC levels
were highly associated with AMD (P b .001) with a beta coefﬁcient of
11.327, indicating that each additional 0.1-unit increase in relative
plasma 24-HC levels was associated with a 3.10-fold increase in odds
of having AMD (95% CI: 1.66 to 5.79).
Fig. 4. Age affects human peripheral blood mononuclear cell (PBMC) and plasma oxysterol signatures. (a-b) There was a signiﬁcant negative correlation between age and PBMC 7-KC
levels, PBMC C-triol levels, and PBMC 24-HC levels in healthy human subjects. (c-d) There was a signiﬁcant positive correlation between age and plasma C-triol levels and a trend
towards a positive correlation between age and plasma 4β-HC levels. Open circles depict individual data points; lines depict the best-ﬁtting linear regression line (a-d; r = Pearson
product-moment correlation coefﬁcient; rs = Spearman rank-order correlation coefﬁcient).
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Furthermore, we performed conjunctive analysis to evaluate the
clinical utility of using plasma 24-HC to discriminate between AMD pa-
tients and non-AMD subjects across varying ages. We divided patients
into tertiles by plasma 24-HC levels and by age (i.e., above versus
below median), tabulating the AMD prevalence in each conjoined cell
(Table 6). This analysis demonstrated a clear stepwise increase in prev-
alence of AMD in subjects above the median age going from the lowest
to the highest tertile of plasma 24-HC (i.e., from 47.1% to 66.7% to 76.2%;
Fig. 6a). We observed a similar increase in AMD prevalence in subjects
below the median age based on plasma 24-HC tertile (i.e., from 10.5%
to 19.0% to 38.5%). These ﬁndings support the notion that plasma 24-
HC levels can distinguish between the changes in cholesterol homeosta-
sis expected during physiologic aging versus those that suggest risk of
AMD. To determine the efﬁcacy of plasma 24-HC levels as a potential
marker for AMD, we generated a receiver operating characteristic
(ROC) curve and found that the area under the ROC curve (AUC) was
0.866 (95% CI: 0.793 to 0.939), indicating good discrimination (Fig. 6b).
To determine the clinical utility of plasma 24-HC levels compared to
existing clinical measures of lipid homeostasis, we next analyzed
whether plasma 24-HC levels were correlatedwith total plasma choles-
terol levels in the subjects for whom this information was available. In
these subjects (N = 37), plasma 24-HC was indeed correlated with
total plasma cholesterol (R= 0.659, P b .001). We therefore performed
a subanalysis by generating a binary logistic regression for the outcome
of AMD with forced entry of plasma 24-HC levels, total plasma choles-
terol, age, and gender. This model was statistically signiﬁcant (LR Χ2
Fig. 5. Age-relatedmacular degeneration (AMD) patients have altered peripheral bloodmononuclear cell (PBMC) and plasma oxysterol signatures. (a-j) Wemeasured PBMC and plasma
levels of 4β-HC, 7-KC, C-triol, 24-HC, and 27-HC. AMD patients (N=44–45) had decreased PBMC 7-KC levels (b; 2-tailedMann-Whitney U test), elevated plasma 4β-HC levels (f; 2-tailed
Mann-Whitney U test), elevated plasma C-triol levels (h; 2-tailed Mann-Whitney U test), elevated plasma 24-HC levels (i; 2-tailed Mann-Whitney U test), and a trend towards elevated
plasma 27-HC levels (j; 2-tailed, unpaired t-test) compared to non-AMD controls (N= 61). Open circles depict individual data points; horizontal lines depict mean ± 95% conﬁdence
intervals (a-j) (* P b .05; ** P b .01; *** P b .001).
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=27.2, df=4, P b .001) and had goodﬁt (Χ2=2.6, df=7, P=.921). Of
interest, total plasma cholesterol levels were not associated with AMD
(aOR = 1.014; 95% CI: 0.97 to 1.06; P= .547). Remarkably, even after
controlling for total plasma cholesterol, age, and gender, plasma 24-
HC remained associated with AMD (P = .044) with a beta coefﬁcient
of 19.308, indicating that each additional 0.1-unit increase in relative
plasma 24-HC levels was associated with a 6.90-fold increase in odds
of having AMD (95% CI: 1.05 to 45.09). Despite the limited sample size
available for this subanalysis, these ﬁndings suggest that human plasma
24-HC has strong diagnostic value compared to the existing measure of
total plasma cholesterol.
Given the heterogeneity of the clinical progression of AMD and our
interest in identifying factors that may predict transition to advanced
disease, we also examinedwhether plasma 24-HC levels differed signif-
icantly when subdividing AMD patients into early AMD and advanced
neovascular AMD patients. We did not detect a statistically signiﬁcant
difference in plasma 24-HC levels in early AMD versus advanced
neovascular AMD patients (Fig. 6c). Therefore, although 24-HC may be
associated with AMD, it does not appear to have utility for predicting
disease progression based on this cross-sectional analysis.
4. Discussion
In this study, we identiﬁed that despite their self-renewal, macro-
phages from old mice exhibit signs of aging, such as defects in mito-
chondrial oxidative respiration, that are not observed in macrophages
from young mice. Consistent with these functional changes, aged mac-
rophages exhibit an altered transcriptomic proﬁle, especially in genes
involved in cholesterol homeostasis. These ﬁndings build on our previ-
ous study reporting that Abca1 expression is signiﬁcantly reduced in
aged macrophages, leading to impaired cholesterol efﬂux [17]. We
further demonstrate that impairments in cholesterol homeostatic
mechanisms are not restricted solely to efﬂux but globally affect myriad
pathways, including biosynthesis, elimination, transport, and regula-
tion. Interestingly, aged macrophages exhibited simultaneous down-
regulation and upregulation of different genes having similar
functions in cholesterol-related pathways (Table 2), indicating broad
and complex dysregulation of cholesterol homeostasis.
Our hypothesis that impaired cholesterol metabolism in aged mac-
rophages contributes to AMDpathogenesis is consistentwith numerous
epidemiological studies that have established that parameters related to
lipid status, such as baseline high-density lipoprotein-cholesterol (HDL-
C) and total serum cholesterol, affect risk of AMDdevelopment and pro-
gression [36–38]. Moreover, one past genome-wide association study
reported that polymorphisms in lipid-related genes such as LIPC,
ABCA1, and CETP are associated with advanced AMD [20]. These ﬁnd-
ings have led to the hypothesis that statins, cholesterol-lowering
drugs used for cardiovascular disease, may affect the development or
progression of AMD [39]. The ﬁndings of one non-randomized study
suggest that high-dose statins may indeed reduce some high-risk fea-
tures of AMD [40], although large randomized studies are necessary to
conﬁrm these ﬁndings [41] given that numerous other studies report
conﬂicting results [42]. Cumulatively, these conﬂicting ﬁndings high-
light that the relationship between aging, impaired cholesterol homeo-
stasis, and AMD is complex and warrants further investigation.
In this study, we found that in aged murine macrophages, a
transcriptomic proﬁle suggesting impaired cholesterol homeostasis
was associated with aberrant intracellular oxysterol levels, especially
when the macrophages were treated with oxLDL. In many immune
cells, oxysterols can directly regulate liver X receptor (LXR) transcrip-
tional activity, which can modulate cellular lipid metabolism and the
immune response, especially in inﬂammation-associated diseases [33].
For example, 27-HC, the most prevalent oxysterol in atherosclerotic le-
sions, has been shown to promote atherosclerosis by inducing inﬂam-
mation [43]. Therefore, in addition to being a surrogate marker for
impaired cholesterol homeostasis, altered oxysterol production may it-
self play a pathogenic role in promoting cholesterol dysregulation. Fur-
ther studies are necessary to uncover the mechanisms underlying
altered oxysterol content, which may be related to altered uptake or
synthesis. However, our results broadly suggest that altered oxysterols
in macrophages are markers of cholesterol dyshomeostasis.
We found that, similar to murine macrophages, human PBMC and
plasma samples demonstrated age-dependent and disease-dependent
changes in oxysterols. Although the directionality of these changes did
not correspond perfectly between mice and humans, our data suggest
that broad dysregulation of cholesterol homeostasis in both aging and
disease is associated with altered oxysterol signatures. These ﬁndings
build on recent reports that monocytes isolated from patients with
neovascular AMD do indeed exhibit an altered immune-related
transcriptomic signature [44] and that these cells, when activated into
macrophages, demonstrate proangiogenic characteristics thatmay con-
tribute to disease pathogenesis [45]. Past studies have also shown that
in the outer retina, accumulation of cholesterol oxidation products
such as 7-KC can disrupt the immune environment and transform resi-
dent macrophages into disease-promoting cells [46]. Speciﬁcally, up-
take of 7-KC in microglial cells results in decreased production of
neurotrophic growth factors and increased expression of angiogenic
mediators that promote pathologic CNV [46]. Although there are likely
some differences between the mechanisms of altered oxysterols in
mice and humans, our work support the broad idea that oxysterols
can be used to identify features of cholesterol dyshomeostasis.
How to distinguish whether changes in oxysterol signatures deﬁne
aging, disease, or both is of great interest, as defects in lipid metabolism
are a shared feature of multiple diseases. As an example, certain
oxysterols and their metabolites have been shown to be speciﬁc bio-
markers for Niemann-Pick type C (NPC) disease, an inherited lysosomal
storage disease [47, 48]. In this study, we found that after controlling for
age and gender, plasma 24-HC was signiﬁcantly associated with AMD.
Despite our modest sample size (N = 107), these ﬁndings suggest
that 24-HC is a strong candidate for an oxysterol that distinguishes
AMD from physiologic aging. Although limited by sample size and
therefore a relatively wide conﬁdence interval, our subanalysis revealed
that plasma 24-HC remained associated with AMD even after control-
ling for total plasma cholesterol, highlighting its diagnostic value. Larger
prospective studies are necessary to validate these ﬁndings and identify
additional markers of risk.
Table 6
AMD as a function of age and plasma 24-HC levels.
Age
Below median Above median Total
Plasma 24-HC Lowest tertile 2/19 (10.5%) 8/17 (47.1%) 10/36 (27.8%)
Middle tertile 4/21 (19.0%) 10/15 (66.7%) 14/36 (38.9%)
Highest tertile 5/13 (38.5%) 16/21 (76.2%) 21/34 (61.8%)
Total 11/53 (20.8%) 34/53 (64.2%) 45/106 (42.5%)
Table 5
Beta coefﬁcients from plasma binary logistic regression model.
Predictor variable aOR (eβ) 95% CI of eβ P-value
Age 1.113 1.055 to 1.174 b0.001
Female gender 0.390 0.119 to 1.282 0.121
Plasma 24-HC levels, 0.1-unit 3.104 1.66 to 5.79 b0.001
Table 4
Beta coefﬁcients from PBMC binary logistic regression model.
Predictor variable aOR (eβ) 95% CI of eβ P-value
Age 1.103 1.049 to 1.161 b0.001
Female gender 0.893 0.335 to 2.381 0.821
PBMC 7-KC levels, 1-unit 0.351 0.087 to 1.412 0.140
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Cumulatively, our ﬁndings highlight that impaired cholesterol
homeostasis is a key pathway perturbed in aged macrophages
and that oxysterol signatures in patient samples can distinguish
AMD from physiologic aging. Ultimately, these ﬁndings may not
only improve our ability to diagnose disease but also identify tar-
gets in cholesterol homeostasis pathways for novel therapeutic
approaches.
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